Use of read-across and computer-based predictive analysis for the safety assessment of PEG cocamines.
暂无分享,去创建一个
Karen Blackburn | Shengde Wu | Stephanie Ringeissen | Julie A Skare | Thomas A Re | Daniel Duche | Donald L Bjerke | Viny Srinivasan | Carol Eisenmann | Shengde Wu | J. Skare | K. Blackburn | T. Re | D. Bjerke | D. Duché | S. Ringeissen | V. Srinivasan | Carol Eisenmann
[1] Karen Blackburn,et al. A framework to facilitate consistent characterization of read across uncertainty. , 2014, Regulatory toxicology and pharmacology : RTP.
[2] S. Jh,et al. Comparative 90-Day Feeding Study with Low-Viscosity White Mineral Oil in Fischer-344 and Sprague-Dawley-Derived CRL:CD Rats , 1995 .
[3] Catherine Mahony,et al. Case studies to test: A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. , 2011, Regulatory toxicology and pharmacology : RTP.
[4] J. Saurat,et al. A safety assessment of branched chain saturated alcohols when used as fragrance ingredients. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[5] Stephen C. DeVito,et al. General Principles for the Design of Safer Chemicals: Toxicological Considerations for Chemists , 1996 .
[6] K. Toyoda,et al. Lack of carcinogenicity of medium-viscosity liquid paraffin given in the diet to F344 rats. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[7] J. Nilsson,et al. Novel hydroperoxides as primary autoxidation products of a model ethoxylated surfactant , 2002 .
[8] Karen Blackburn,et al. A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. , 2010, Regulatory toxicology and pharmacology : RTP.
[9] Claudia Fruijtier-Pölloth. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. , 2005, Toxicology.
[10] J. Stadler,et al. PEGylated Proteins: Evaluation of Their Safety in the Absence of Definitive Metabolism Studies , 2007, Drug Metabolism and Disposition.
[11] H. Greim,et al. Toxicity of aliphatic amines: structure-activity relationship. , 1998, Chemosphere.
[12] D. Morton,et al. A Strategy for Risk Management of Drug-Induced Phospholipidosis , 2009, Toxicologic pathology.
[13] R. Ulrich,et al. Drug-induced phospholipidosis: issues and future directions , 2006, Expert opinion on drug safety.
[14] A Burger,et al. Isosterism and bioisosterism in drug design. , 1991, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.